Pat Donnelly, executive chairman at Veranex, has been a pharma services founder and executive for over 25 years. He was chairman and CEO of Advarra, Inc., until 2020, and chairman and CEO, from initial formation and sale, of Aptiv Solutions from 2009 to 2014; and also formed PRA International (now PRA Health Sciences, NASDAQ: PRAH) with three other partners, serving as CFO, COO, and CEO over the span of 14 years, taking PRA public in 2004.
He has initiated and closed over 39 acquisitions and global integrations and eight separate successful exit transactions, averaging over 4x investors’ money. Pat has a B.S. in business and journalism from the University of Missouri and an MBA from The Pennsylvania State University.